Purpose: to evaluate the safety and tolerability of a potential new drug for the purpose of treating a variety of conditions where the body does not correctly process cholesterol

4 nights
1 visits

Participate in a clinical study of a potential treatment for atherosclerosis.

This study has 1 screening appointment and 3 nights/ 4 days inpatient stay.

Reimbursement for study participation will be provided for time and travel of up to $2,197.

We are looking at how this investigational medication is processed in people with renal impairment compared to those with normal renal function.

This study has been reviewed by an Institutional Review Board.

Call 612-315-6490 to discuss your eligibility today!


Age: 18 +
BMI: 18-42 kg/m2
Medications: Medications must be stable for >4 weeks. Minor changes in medication regimen are acceptable with approval
Smoking: Non-smokers and smokers are allowed if they agree to follow clinic policy
Compensation: Up to $2,197